This guide is educational information, not personal medical advice. The source-check date records editorial work, not a clinician review. Read our medical disclaimer.

Choosing the question the NAT should answer

A NAT looks for the virus itself, but the purpose of the order matters. A clinician evaluating a possible recent infection is answering a different question from a care team using a viral-load measurement to monitor someone already known to have HIV. Ask the ordering clinician which question the test addresses.

CDC gives a usual detection window of 10–33 days after exposure for NAT. A negative result before the test can detect an infection is not a final answer for that event. A clinician may consider NAT when recent exposure and symptoms raise concern despite a negative antibody or antigen/antibody test.

PrEP, PEP, and HIV treatment medicines can delay detection. Tell the clinician the products and dates. After nonoccupational PEP, CDC describes a diagnostic NAT together with a laboratory antigen/antibody test as part of follow-up, including final testing at 12 weeks after PEP initiation.

Sources for this section: [1][2][3]

What a NAT measures

A nucleic acid test, or NAT, looks for HIV in blood. A provider draws blood from a vein and sends it to a laboratory. CDC says a NAT can usually detect HIV 10–33 days after exposure; this range can be affected by antiretroviral medicine.

A NAT can be used to detect HIV or measure the amount of virus in blood. The reason for ordering it matters: a viral-load measurement in someone already diagnosed answers a different practical question from evaluating a new possible infection.

Sources for this section: [1][2]

When it may be useful

CDC says a NAT should be considered when someone has had a recent possible exposure and early symptoms but has a negative antibody or antigen/antibody result. It may also be used as part of follow-up after PEP or when other results are unclear.

The clinician chooses a diagnostic approach using the full history. Ask what the test is intended to answer, whether another test is needed, and when results are expected.

Sources for this section: [1][3]

Understand limitations

An early negative NAT cannot exclude an exposure that occurred too recently for detection. Antiretroviral medicines can also delay detection, so report recent PrEP, PEP, or treatment.

If results are reactive or disagree, the testing service may need another sample or supplemental testing. Ask for a concrete follow-up date and a way to contact the service if results are delayed.

Sources for this section: [2][1]

Check the source

Sources & editorial note

We use the sources below to support this guide. Follow a source link for its full guidance and any later changes. Source checking does not replace medical review or a conversation with your care team.

  1. Getting Tested for HIV CDC. Accessed .
  2. HIV Testing CDC. Accessed .
  3. Antiretroviral Postexposure Prophylaxis: CDC Recommendations, 2025 CDC. Accessed .

Prepared by HIV Guide editorial team. How we write and check our guides · Contact and corrections information